Vancomycin Resistant Enterococci (VRE) Clinical Trials

A listing of Vancomycin Resistant Enterococci (VRE) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 6 clinical trials
An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection

urine and feces; To assess C. difficile using microbiological assessments; To assess the proportion of subjects colonized with vancomycin-resistant enterococci (VRE), extended

  • 29 views
  • 07 Oct, 2022
  • 6 locations
Carriage Clearance of Emerging Highly Resistant Bacteria in Chronic Dialysis Patients (DIACOBHR)

bacteremia in healthcare establishments in France at less than 1%, and that of Vancomycin Resistant Enterococcus (VRE) belonging to Enterococci Resistant to Glycopeptides (ERG) such as Enterococcus faecium

chronic dialysis
dialysis
antibiotics
chronic renal failure
renal failure
  • 0 views
  • 27 Apr, 2022
  • 5 locations
Safety and Efficacy of Fecal Microbiota Transplantation

encephalopathy, multiple sclerosis, pseudo-obstruction, carbapenem-resistant Enterobacteriaceae (CRE) or Vancomycin-resistant Enterococci (VRE) infection, radiation-induced toxicity, multiple organ dysfunction

diabetes mellitus
liver disease
hepatic encephalopathy
hepatitis
disease or disorder
  • 427 views
  • 23 Mar, 2022
  • 1 location
Fecal Microbiota Transplantation Effect on Amyotrophic Lateral Sclerosis Patients (FETR-ALS)

Given the role of adaptive immunity in ALS, the pathogenicity of some clostridial strains on motorneurons, the putative role of cyanobacteria in ALS development, and the increasing interest for microbiota in neurodegenerative disorders, the modification of intestinal microbiota might affect ALS at its core. This interventional study aims at evaluating …

primary lateral sclerosis
neurodegenerative disorders
riluzole
  • 112 views
  • 11 Mar, 2022
  • 1 location
Carbapenemase-Producing Organism and Vancomycin-Resistant Enterococcus Management (CPO-VRE)

Emergence of vancomycin-resistant enterococci (VRE) and carbapenemase-producing enterobacteria (CPE) is nowadays a major public health concern worldwide. VRE and CPE are referred to as Emerging

  • 0 views
  • 09 Apr, 2022
  • 1 location
Investigation of the Correlation Between Plasma Concentration of Linezolid Antibiotic and Treatment Response and Adverse Reactions

Linezolid is the second line agent in the treatment of MRSA and PRSP infections, and it is also the drug of choice for VRE infections. It can be an alternative option against multidrug resistant tuberculosis and non-tuberculosis mycobacterium. However, Patients who receive more than 2 weeks of treatment duration and …

tuberculosis
neuropathy
  • 46 views
  • 23 Mar, 2022
  • 1 location